Alopecia Clinical Trials

A listing of Alopecia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Arizona

Tucson Arizona 85724

A clinical trial to evaluate treatments using 7% (w/v) Tempol alcohol-based gel (MTS-01) and alcohol-based gel for patients with Alopecia

California

Irvine California 92618

A clinical trial seeking patients for a research study for the treatment of Alopecia Areata or Scarring Alopecia

Irvine California 92618

A clinical trial seeking patients for a research study for the treatment of Hair Disease

Irvine California 92697

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

Palo Alto California 94304

A clinical trial seeking patients for a research study for the treatment of Androgenic Alopecia

Rancho Mirage California 92270

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

View More ▼

Redwood City California 94064

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

Santa Monica California 90404

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Connecticut

New Haven Connecticut 06519

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

New Haven Connecticut 06510

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

New Haven Connecticut 06510

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

New Haven Connecticut 06519

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

New Haven Connecticut 06510

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

View More ▼

New Haven Connecticut 06511

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Florida

Orange Park Florida 32073

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Orange Park Florida 32073

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Tampa Florida 33609

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Tampa Florida 33609

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Georgia

Newnan Georgia 30263

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Illinois

Chicago Illinois 60611

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

Skokie Illinois 60077

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Indiana

Indianapolis Indiana 46256

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Indianapolis Indiana 46256

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Massachusetts

Boston Massachusetts 02111

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Minnesota

Fridley Minnesota 55432

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

Montana

Stevensville Montana 59870

A clinical trial seeking patients for a research study for the treatment of Alopecia Areata or Scarring Alopecia

New York

Mount Sinai Medical Center
New York New York 10029

An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata

Sadick Research Group
New York New York 10075

Study to Evaluate Safety and Efficacy of a Nutraceutical Supplement with Standardized Botanicals for Treatment of Hair Loss and Thinning in Females

View More ▼

New York New York 10029

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

Rochester New York 14642

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Rochester New York 14642

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Oklahoma

Tulsa Oklahoma 74136-7028

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Oregon

Portland Oregon 97210

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

Pennsylvania

Philadelphia Pennsylvania 19104

A clinical trial to evaluate treatments using 7% (w/v) Tempol alcohol-based gel (MTS-01) and alcohol-based gel for patients with Alopecia

Texas

Research Across America, Plano
Plano Texas 75093

Hair Loss Study For Men & Women

View More ▼

Houston Texas 77056

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

Virginia

Norfolk Virginia 23502

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Canada

Markham Ontario L3P 1X2

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Richmond Hill Ontario L4B 1A5

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Richmond Hill Ontario L4C 9M7

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Winnipeg Manitoba R3M 3Z4

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

France

Paris

A clinical study for patients with Alopecia

Paris

A clinical study for patients with Alopecia

Paris

A clinical study for patients with Alopecia

Germany

Berlin 10115

Drug Utilization Study on the Prescribing Indications for Cyproterone Acetate and Ethinyl Estradiol in 5 European Countries

Berlin 10117

Patients are needed to participate in a clinical research study evaluating FOL-005 and Placebo for the treatment of Hypertrichosis, Alopecia or Hirsutism

India

Gurgaon 122002

A clinical study for patients with Alopecia

New Delhi 110088

A clinical study for patients with Alopecia

Romania

Bucharest

A clinical study for patients with Alopecia